Literature DB >> 11096127

New insights into the paradoxical effect of thiazides in diabetes insipidus therapy.

A J Magaldi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11096127     DOI： 10.1093/ndt/15.12.1903

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  11 in total

1.  Efficacy of COX-2 inhibitors in a case of congenital nephrogenic diabetes insipidus.

Authors:  Alper Soylu; Belde Kasap; Nilüfer Oğün; Yeşim Oztürk; Mehmet Türkmen; Lies Hoefsloot; Salih Kavukçu
Journal:  Pediatr Nephrol       Date:  2005-10-21       Impact factor: 3.714

Review 2.  New insights into the dynamic regulation of water and acid-base balance by renal epithelial cells.

Authors:  Dennis Brown; Richard Bouley; Teodor G Păunescu; Sylvie Breton; Hua A J Lu
Journal:  Am J Physiol Cell Physiol       Date:  2012-03-28       Impact factor: 4.249

3.  Central Diabetes Insipidus Masked by Uncontrolled Diabetes Mellitus: A Challenging Case Managed With Indapamide.

Authors:  Eyleen Gonzalez; Lorena Nuñez; Yavelkis Perez; Indira Atencio; Alex Pineda; Myron Miller; Stanley M Chen Cardenas
Journal:  Cureus       Date:  2022-02-04

Review 4.  Vasopressin receptor antagonists in patients with chronic heart failure.

Authors:  R De Vecchis; C Cantatrione; D Mazzei
Journal:  Herz       Date:  2016-09-15       Impact factor: 1.443

5.  Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitor.

Authors:  Anirut Pattaragarn; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2003-07-18       Impact factor: 3.714

Review 6.  Arginine vasopressin (AVP): a review of its historical perspectives, current research and multifunctional role in the hypothalamo-hypophysial system.

Authors:  Fabio Rotondo; Henriett Butz; Luis V Syro; George M Yousef; Antonio Di Ieva; Lina M Restrepo; Andres Quintanar-Stephano; Istvan Berczi; Kalman Kovacs
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

7.  Nrf2 activation protects against lithium-induced nephrogenic diabetes insipidus.

Authors:  Soma Jobbagy; Dario A Vitturi; Sonia R Salvatore; Maria F Pires; Pascal Rowart; David R Emlet; Mark Ross; Scott Hahn; Claudette St Croix; Stacy G Wendell; Arohan R Subramanya; Adam C Straub; Roderick J Tan; Francisco J Schopfer
Journal:  JCI Insight       Date:  2020-01-16

Review 8.  Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?

Authors:  Renato De Vecchis; Claudio Cantatrione; Damiana Mazzei; Cesare Baldi
Journal:  J Clin Med       Date:  2016-10-02       Impact factor: 4.241

9.  A Rare Case of Congenital Diabetes Insipidus.

Authors:  Tanvi Rege; Srujana Polsani; Belinda Jim
Journal:  Front Med (Lausanne)       Date:  2015-07-07

10.  Novel AQP2 Mutations and Clinical Characteristics in Seven Chinese Families With Congenital Nephrogenic Diabetes Insipidus.

Authors:  Qian Li; Dan Tian; Jing Cen; Lian Duan; Weibo Xia
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-10       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.